3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Gastrointestinal Stromal Tumors
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Melanoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Blast Crisis
1
Interventions
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Mycophenolic Acid
2
Busulfan
2
Biopsy
2
talimogene laherparepvec
1
pembrolizumab
1
fludarabine
1
duvelisib
1
Vincristine
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Brentuximab Vedotin
1
Blood Specimen Collection
1
Aclarubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
Imatinib Mesylate
×
90 days
×
Clear all
No trials found.